Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | THRB | P10828 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | USP2 | O75604 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.41 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.38 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.36 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.36 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29521479 | 1.00 | MEN1 (0.58) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL2369348 | 0.98 | MEN1 (0.55) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL2369313 | 0.98 | MEN1 (0.55) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL24266 | 0.98 | MEN1 (0.55) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL25363941 | 0.93 | TSHR (0.52) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL31601754 | 0.93 | TSHR (0.52) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL3362082 | 0.93 | TSHR (0.52) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL5146487 | 0.93 | MEN1 (0.62) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL1628205 | 0.93 | MEN1 (0.62) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL1626655 | 0.93 | MEN1 (0.62) | MEN1KMT2ATHRBHTTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2514406-A1 | Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier | Novo Nordisk A/S (DK) | 2012-10-24 | — | — | EP | disclosed |
| EP-2497462-A1 | Stable non-aqueous pharmaceutical compositions | Novo Nordisk A/S (DK) | 2012-09-12 | — | — | EP | disclosed |
| US-20100190706-A1 | Stable Non-Aqueous Pharmaceutical Compositions | NOVO NORDISK A/S (DK) | 2010-07-29 | — | — | US | disclosed |
| EP-2164466-A1 | SPONTANEOUSLY DISPERSIBLE PRECONCENTRATES INCLUDING A PEPTIDE DRUG IN A SOLID OR SEMISOLID CARRIER | Novo Nordisk A/S (DK) | 2010-03-24 | — | — | EP | disclosed |
| EP-2164459-A1 | STABLE NON-AQUEOUS PHARMACEUTICAL COMPOSITIONS | Novo Nordisk A/S (DK) | 2010-03-24 | — | — | EP | disclosed |
| WO-2008145732-A1 | STABLE NON-AQUEOUS PHARMACEUTICAL COMPOSITIONS | NOVO NORDISK A/S (DK) | 2008-12-04 | — | — | WO | disclosed |
| WO-2008145728-A1 | SPONTANEOUSLY DISPERSIBLE PRECONCENTRATES INCLUDING A PEPTIDE DRUG IN A SOLID OR SEMISOLID CARRIER | NOVO NORDISK A/S (DK) | 2008-12-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100190706-A1 | Stable Non-Aqueous Pharmaceutical Compositions | IAPP, NONO, GPR119 | MEN1 1062/4885KMT2A 4672/4885THRB 1473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.